Pharmacokinetics and tumor delivery of nanoparticles
Nanoparticles (NPs) have been widely used in different areas, including consumer products
and medicine. In terms of biomedical applications, NPs or NP-based drug formulations have …
and medicine. In terms of biomedical applications, NPs or NP-based drug formulations have …
Oral delivery of nucleic acid therapies for local and systemic action
Nucleic acid (NA) therapy has gained importance over the past decade due to its high
degree of selectivity and minimal toxic effects over conventional drugs. Currently …
degree of selectivity and minimal toxic effects over conventional drugs. Currently …
Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers
A Rajput, P Pingale, D Telange, S Chalikwar… - Journal of Drug Delivery …, 2021 - Elsevier
The oral route of administration for lipid-based nanocarriers is of immense importance for
the drugs having low bioavailability because of extensive first-pass metabolism. These drug …
the drugs having low bioavailability because of extensive first-pass metabolism. These drug …
Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection
CR Garcia, AT Rad, F Saeedinejad, A Manojkumar… - …, 2022 - Taylor & Francis
Background: Combination antiretroviral therapy has significantly advanced HIV-1 infection
treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood …
treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood …
Enantioselective oral absorption of molecular chiral mesoporous silica nanoparticles
Y Wang, L Zhao, Y Dai, M Xu, R Zhou… - Advanced …, 2023 - Wiley Online Library
Inspired by the unique pharmacological effects of chiral drugs in the asymmetrical body
environments, it is assumed that the chirality of nanocarriers is also a key factor to determine …
environments, it is assumed that the chirality of nanocarriers is also a key factor to determine …
[HTML][HTML] Recent progress in application of nanovaccines for enhancing mucosal immune responses
G Du, M Qin, X Sun - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Mucosal vaccines that stimulate both mucosal and systemic immune responses are
desirable, as they could prevent the invading pathogens at their initial infection sites in a …
desirable, as they could prevent the invading pathogens at their initial infection sites in a …
[HTML][HTML] Verapamil hydrochloride loaded solid lipid nanoparticles: Preparation, optimization, characterisation, and assessment of cardioprotective effect in …
Verapamil, a calcium channel blocker has poor bioavailability (20–30%) owing to extensive
hepatic first-pass metabolism. Hence, the major objective of this research was to improve the …
hepatic first-pass metabolism. Hence, the major objective of this research was to improve the …
Interactions between nanoparticles and intestine
M Vitulo, E Gnodi, R Meneveri, D Barisani - International Journal of …, 2022 - mdpi.com
The use of nanoparticles (NPs) has surely grown in recent years due to their versatility, with
a spectrum of applications that range from nanomedicine to the food industry. Recent …
a spectrum of applications that range from nanomedicine to the food industry. Recent …
Assembly of nanostructured lipid carriers loaded gefitinib and simvastatin as hybrid therapy for metastatic breast cancer: Codelivery and repurposing approach
Breast cancer represents a lifethreatening problem globally. The major challenge in the
clinical setting is the management of cancer resistance and metastasis. Hybrid therapy can …
clinical setting is the management of cancer resistance and metastasis. Hybrid therapy can …
Nanocarriers based oral lymphatic drug targeting: Strategic bioavailability enhancement approaches
In dosage form design, drug delivery technology facing a major problem due to degradation
of the drug through the first-pass metabolism upon oral delivery. We can overcome this …
of the drug through the first-pass metabolism upon oral delivery. We can overcome this …